Product image of Kasiniv (Caspofungin) supplied by GNH India

Kasiniv

Active Ingredient:
Caspofungin
Origin:
EU

Kasiniv (Caspofungin)

Caspofungin, the active ingredient in Kasiniv, is an echinocandin presented as an intravenous formulation for use in hospitalized patients with serious fungal infections such as invasive candidiasis and aspergillosis. It is administered under medical supervision to treat life‑threatening infections caused by susceptible Candida and Aspergillus species.

GNH India supplies Kasiniv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Pharma Bavaria Internacional (Pbi) Portugal Unipessoal Lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kasiniv (caspofungin) is used to treat invasive fungal infections by targeting the cell wall of susceptible yeasts and molds.

  • Invasive candidiasis: effective for bloodstream and deep‑tissue infections caused by Candida species.
  • Candida auris infections: provides treatment option for this multidrug‑resistant yeast.
  • Invasive aspergillosis: used in patients with proven or probable aspergillosis when other therapies are unsuitable.

How It Works

  • Caspofungin inhibits the enzyme β‑(1,3)‑D‑glucan synthase, which is essential for synthesizing β‑(1,3)‑D‑glucan, a critical component of the fungal cell wall. By disrupting cell‑wall integrity, the drug leads to osmotic instability and fungal cell death, while having minimal effect on human cells that lack this pathway. The inhibition is non‑competitive and results in a fungicidal effect against most Candida species and a fungistatic effect against Aspergillus.

Side Effects

Caspofungin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Fever: transient elevation of body temperature.
  • Chills: shaking sensation often accompanying infusion.
  • Elevated liver enzymes: mild increase in ALT or AST.
  • Nausea: occasional feeling of stomach upset.

Serious or Rare Side Effects

  • Hypersensitivity reactions: rash, urticaria, or anaphylaxis.
  • Hepatotoxicity: significant rise in liver enzymes or jaundice.
  • Severe infusion‑related reactions: hypotension or bronchospasm.
  • Renal impairment: acute kidney injury in susceptible patients.

Precautions & Warnings

When using Kasiniv, clinicians should consider several precautionary measures to ensure safe administration.

  • Renal function: assess baseline creatinine and monitor during therapy.
  • Hepatic function: evaluate liver enzymes before initiation and periodically.
  • Concomitant medications: review for potential interactions, especially with cytochrome P450 substrates.
  • Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited.
  • Infusion monitoring: observe patients for signs of hypersensitivity during and after infusion.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Caspofungin can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Cytochrome P450 inducers (e.g., rifampin, carbamazepine): may reduce caspofungin exposure.
  • Strong immunosuppressants (e.g., tacrolimus) combined with high‑dose caspofungin: increased risk of toxicity.

Moderate Interactions (Monitor Closely)

  • Azole antifungals (e.g., fluconazole): may alter plasma levels; monitor clinical response.
  • Warfarin: potential for altered anticoagulation; check INR regularly.
  • Diuretics (e.g., furosemide): may affect renal handling; monitor kidney function.

Frequently Asked Questions

Kasiniv contains the antifungal agent caspofungin and is indicated for the treatment of serious invasive fungal infections, including invasive candidiasis, infections caused by Candida auris, and invasive aspergillosis in patients who require intravenous therapy.

Caspofungin blocks the enzyme β‑(1,3)‑D‑glucan synthase, preventing the synthesis of β‑(1,3)‑D‑glucan, an essential structural component of the fungal cell wall. This disruption weakens the wall, leading to cell lysis and death of susceptible fungi.

The dosage of Kasiniv is determined by the prescribing clinician based on the type and severity of the infection, patient weight, renal and hepatic function, and other clinical factors. No fixed regimen is provided here; the prescriber sets the appropriate dose.

Safety data for caspofungin in pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by the treating physician.

To order Kasiniv, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

The primary alternative class for invasive candidiasis and aspergillosis is the azole antifungals (e.g., fluconazole, voriconazole). Compared with azoles, caspofungin has a different mechanism, is less affected by azole‑resistance mechanisms, and is often used when azoles are contraindicated or ineffective, though it requires intravenous administration.

Kasiniv should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the product in its original packaging until use and follow aseptic techniques during preparation for infusion.

Kasiniv is administered by intravenous infusion. The infusion is typically given over a period of one hour, but the exact rate and duration are determined by the prescribing physician based on patient condition and institutional protocols.

Serious risks include hypersensitivity reactions such as rash, urticaria or anaphylaxis, significant liver enzyme elevations indicating hepatotoxicity, severe infusion‑related events like hypotension or bronchospasm, and rare cases of acute kidney injury. Prompt medical attention is required if any of these occur.

Kasiniv is contraindicated in patients with a known hypersensitivity to caspofungin or any component of the formulation. Caution is also advised for patients with severe hepatic impairment, and it should be avoided in individuals where alternative therapies are appropriate and safer.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Caspofungin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT